Lamb Weston Trims FY22 Sales Growth Outlook As Q1 Results Miss Estimates - Quick Facts

While reporting financial results for the first quarter on Thursday, Lamb Weston Holdings, Inc. (LW) said it now projects net sales growth for the full-year 2022 to be above its long-term target range of low-single digits.

Previously, net sales growth was expected to be above its long-term target of low-to-mid single digits.

On average, seven analysts polled by Thomson Reuters expect the company to report a sales growth of 12.4 percent to $4.13 billion for the year.

For the first quarter, the company reported net income of $29.8 million or $0.20 per share, down from $89.3 million or $0.61 per share in the prior-year quarter. Net sales for the quarter grew 13 percent to $984.2 million from $871.5 million in the same quarter last year.

The Street was looking for earnings of $0.38 per share on net sales of $1.0 billion for the quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Frozen Food Development is recalling specific lots of Lidl branded 12-ounce packages of Frozen Chopped Spinach citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The product comes in 12-ounce poly bags, and items included in the recall are marked with lot # R17742 or R17963 on the back of the poly bag with a best by date of 09/10/23. Starbucks has dropped its vaccine or weekly test requirement against Covid-19 for U.S. employees in the wake of last week's U.S. Supreme Court ruling. The court, in a 6-3 vote, has blocked President Joe Biden's vaccine-or-test mandate for private companies with 100 or more employees. However, it allowed the vaccine mandate to stand for certain health care workers. Mylan Pharmaceuticals Inc., affiliated to healthcare company Viatris Inc., is recalling one batch of its non-interchangeable Semglee (insulin glargine injection), 100 units/ml (U-100), 3mL prefilled pens due to the potential for a missing label, the U.S. Food and Drug Administration said.
Follow RTT